GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » InBody Co Ltd (XKRX:041830) » Definitions » Cyclically Adjusted Price-to-FCF

InBody Co (XKRX:041830) Cyclically Adjusted Price-to-FCF : 19.09 (As of Jun. 07, 2025)


View and export this data going back to 2000. Start your Free Trial

What is InBody Co Cyclically Adjusted Price-to-FCF?

As of today (2025-06-07), InBody Co's current share price is ₩24400.00. InBody Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 was ₩1,277.94. InBody Co's Cyclically Adjusted Price-to-FCF for today is 19.09.

The historical rank and industry rank for InBody Co's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

XKRX:041830' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 17.61   Med: 43.64   Max: 175.81
Current: 19.21

During the past years, InBody Co's highest Cyclically Adjusted Price-to-FCF was 175.81. The lowest was 17.61. And the median was 43.64.

XKRX:041830's Cyclically Adjusted Price-to-FCF is ranked better than
71.49% of 249 companies
in the Medical Devices & Instruments industry
Industry Median: 36.39 vs XKRX:041830: 19.21

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

InBody Co's adjusted free cash flow per share data for the three months ended in Mar. 2025 was ₩525.098. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is ₩1,277.94 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


InBody Co Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for InBody Co's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InBody Co Cyclically Adjusted Price-to-FCF Chart

InBody Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 35.25 36.38 24.71 22.93 19.14

InBody Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 26.33 22.65 20.83 19.14 17.41

Competitive Comparison of InBody Co's Cyclically Adjusted Price-to-FCF

For the Medical Devices subindustry, InBody Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


InBody Co's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, InBody Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where InBody Co's Cyclically Adjusted Price-to-FCF falls into.


;
;

InBody Co Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

InBody Co's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=24400.00/1277.94
=19.09

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

InBody Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, InBody Co's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2025 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=525.098/122.5900*122.5900
=525.098

Current CPI (Mar. 2025) = 122.5900.

InBody Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201506 364.512 100.051 446.629
201509 71.167 100.111 87.147
201512 -181.052 100.220 -221.464
201603 190.730 100.561 232.512
201606 382.571 100.791 465.315
201609 -103.699 101.461 -125.294
201612 253.270 101.561 305.711
201703 229.704 102.851 273.789
201706 226.698 102.611 270.837
201709 299.137 103.491 354.344
201712 207.051 102.991 246.453
201803 -96.611 104.101 -113.770
201806 -2,218.439 104.130 -2,611.713
201809 218.242 105.651 253.234
201812 372.695 104.351 437.838
201903 434.300 104.491 509.526
201906 436.888 104.881 510.656
201909 498.335 105.200 580.710
201912 198.830 105.121 231.871
202003 385.883 105.354 449.013
202006 114.657 105.112 133.722
202009 677.726 106.198 782.338
202012 858.708 105.765 995.307
202103 498.199 107.357 568.888
202106 649.730 107.579 740.393
202109 534.272 108.759 602.215
202112 -261.104 109.676 -291.847
202203 279.771 111.848 306.641
202206 307.145 114.072 330.079
202209 653.758 114.715 698.636
202212 632.683 115.179 673.391
202303 693.126 116.507 729.313
202306 714.657 117.182 747.638
202309 378.046 118.964 389.570
202312 597.382 118.837 616.247
202403 506.150 120.123 516.544
202406 346.149 120.007 353.599
202409 486.694 120.861 493.656
202412 281.238 121.135 284.616
202503 525.098 122.590 525.098

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


InBody Co  (XKRX:041830) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


InBody Co Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of InBody Co's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


InBody Co Business Description

Traded in Other Exchanges
N/A
Address
54, Nonhyeon-ro 2-gil, Gangnam-gu, Seoul, KOR, 135-960
InBody Co Ltd is a Korea-based company engaged in the manufacturing and distribution of body composition analyzers. The company mainly produces body composition analyzers under the brand name InBody and Lookin'Body. It's InBody series products include InBody720, InBody570, InBody230, InBody J30, and InBody S10.

InBody Co Headlines

No Headlines